Lavior Pharma Announces The Addition Of Dr. Windy Cole To The Scientific Executive Advisory Board - Lavior

Lavior Pharma Announces The Addition Of Dr. Windy Cole To The Scientific Executive Advisory Board

MIAMI, FL (FEBRUARY 1, 2024) – Lavior Pharma Inc., an international advanced diabetic wound and skincare Company headquartered in Miami, Florida, announced the appointment of Windy Cole, DPM, to the Company’s Scientific Executive Advisory Board. Dr. Cole has been a practicing wound care physician for over 23 years and is an Adjunct Professor and Director of Wound Care Research at Kent State University College of Podiatric Medicine. Dr. Cole is board certified by the American Board of Podiatric Surgery and the American Board of Wound Management. She is an active member of the APMA and OHFAMA. She also sits on the Board of Directors of the American College of Clinical Wound Specialists. Dr. Cole has published numerous peer-reviewed scientific articles and is an recognized expert and international speaker on wound management. She also provides frequent expert commentary to Podiatry ManagementToday’s Wound Clinic, and Podiatry Today.

Dr. Cole shares, “I look forward to joining Lavior’s Scientific Advisory Board. Lavior has developed a line of botanical-based products that has the ability to have a major impact on people who are living with skin complications as a result of diabetes. The company is focused on providing life-saving, safe, effective, and affordable treatments and to address the gap in cost effective and comprehensive treatment.”

Dr. Cole joins other internationally recognized wound care experts and will assist in guiding strategy, research. and product development. Her leadership, experience, and dedication to patients with diabetes will be instrumental in helping Lavior expand their comprehensive product lines and ongoing success in becoming the leader in the wound care market.

“We extend a warm welcome to Dr. Cole as she joins our Scientific Executive Advisory Board. As an international recognized expert wound care clinician, Dr. Cole will bring her vast knowledge and valuable insights to the Company as we continue to provide life-saving treatment to those suffering from diabetes,” says Gilad Savion, the CEO and President of Lavior.

About Lavior Pharma Inc.

LAVIOR is the only company exclusively dedicated to the therapeutic diabetes skin care market.  The LAVIOR skincare product line soothes and heals some of the most widespread and challenging skin problems – diabetic ulcers, wounds, burns, eczema/atopic dermatitis, bacterial and fungal infections, skin irritations, and cracked skin. LAVIOR’s line of products is based on the proven efficacy of the Inula AGS RIED botanical species. They are developed using the highest quality, pharmaceutical grade ingredients; manufactured and tested to deliver safe, effective, and compliant products. Backed by over 13 years of extensive research and clinical trials, proven clinical safety and efficacy, they consistently outperform conventional treatments.

For more information on Lavior Pharma and its products, please visit www.lavior.com

For Media or other Inquiries, please contact:

Anabelle Savion
Managing Director
Phone: (+1) 9178373355
anabelle@lavior.com